N-Heterocyclic Benzhydrylamines as N,N-Bidentate Ligands in Pd Complexes
H]+, 169 (100) [M – NH2]+. HRMS (ESI): calcd. for [M + H]+
Methylation of Amine 1a: To a stirred solution of methylamine 1a
186.1031; found 186.1026.
(362 mg, 1.32 mmol) and K2CO3 (274 mg, 1.98 mmol) in MeCN
(10 mL) was added dropwise methyl iodide (82 µL, 187 mg,
1.32 mmol). The mixture was stirred at room temperature for 16 h,
and the reaction was quenched by addition of saturated aqueous
NaHCO3 solution (15 mL). The aqueous phase was extracted with
EtOAc (3ϫ25 mL), and the combined organic layers were dried
(MgSO4), filtered, and concentrated under vacuum. The crude
product was purified by flash chromatography on silica gel to give
tertiary amine 1d (288 mg, 1 mmol, 76%) as a yellow oil.
Benzylation of Primary Amines: To a stirred solution of biarylme-
thylamine (2 mmol) and MgSO4 (481 mg, 4 mmol) in MeOH
(20 mL) was added benzaldehyde (202 µL, 212 mg, 2 mmol). The
mixture was stirred at room temperature for 12 h, then cooled to
0 °C, and NaBH4 (76 mg, 2 mmol) was added. The reaction mix-
ture was stirred at room temperature for 4 h. The solution was then
concentrated under vacuum, and saturated aqueous NH4Cl solu-
tion (25 mL) were added. The aqueous phase was extracted with
EtOAc (3ϫ25 mL). The combined organic layers were dried
(MgSO4), filtered, and concentrated under vacuum. The crude
product was purified by flash chromatography on silica gel.
N-Benzyl-N-methyl-N-[phenyl(pyridin-2-yl)methyl]amine (1d): Rf =
1
0.45 (20% EtOAc in cyclohexane). H NMR (300 MHz, CDCl3):
δ = 1.98 (s, 3 H), 3.34 (d, J = 13.5 Hz, 1 H), 3.49 (d, J = 13.5 Hz,
1 H), 4.55 (s, 1 H), 6.90 (ddd, J = 1.20, 4.90 and 7.40 Hz, 1 H),
7.05–7.22 (m, 6 H), 7.26–7.29 (m, 2 H), 7.44–7.48 (m, 3 H), 7.59
N-Benzyl-N-[phenyl(pyridin-2-yl)methyl]amine (1a): Yield 490 mg
(90%); yellow oil; Rf = 0.20 (20% EtOAc in cyclohexane). 1H
NMR (300 MHz, CDCl3): δ = 2.88 (s, 1 H, NH), 3.60 (d, J =
13.3 Hz, 1 H), 3.67 (d, J = 13.3 Hz, 1 H), 4.86 (s, 1 H), 6.93 (ddd,
J = 1.0, 4.9, and 7.4 Hz, 1 H), 7.07–7.13 (m, 2 H), 7.16–7.24 (m, 7
H), 7.34–7.37 (m, 2 H), 7.40 (td, J = 1.8 and 7.6 Hz, 1 H), 8.42 (d,
1
(d, J = 7.90 Hz, 1 H), 8.36 (d, J = 4.90 Hz, 1 H) ppm. H NMR
(300 MHz, [D6]dmso): δ = 1.96 (s, 3 H), 3.38 (d, J = 13.5 Hz, 1 H),
3.48 (d, J = 13.5 Hz, 1 H), 4.63 (s, 1 H), 7.19–7.24 (m, 3 H), 7.26–
7.40 (m, 6 H), 7.52–7.55 (m, 2 H), 7.71–7.80 (m, 2 H), 8.46 (d, J
= 4.60 Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 40.2, 59.6,
77.4, 121.8, 121.9, 126.7, 127.1, 128.1 (4 C), 128.4 (2 C), 128.5 (2
1
J = 4.8 Hz, 1 H) ppm. H NMR (300 MHz, [D6]dmso): δ = 3.26
(s, 1 H, NH), 3.62 (t, J = 14.6 Hz, 2 H), 4.85 (s, 1 H), 7.19–7.24
(m, 3 H), 7.25–7.32 (m, 6 H), 7.39–7.43 (m, 2 H), 7.50 (d, J =
7.9 Hz, 1 H), 7.73 (td, J = 1.8 and 7.7 Hz, 1 H), 8.47 (d, J = 4.8 Hz,
1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 50.6, 66.6, 121.4,
122.0, 126.6, 126.9, 127.4 (2 C), 128.0 (2 C), 128.1 (2 C), 128.3 (2
C), 136.5, 139.3, 141.6, 148.8, 162.6 ppm. IR (film): ν = 3083, 3058,
˜
3027, 307, 2955, 2929, 2843, 2786, 1665, 1588, 1496, 1455, 1429,
1588, 1312, 1281, 1132, 1020, 917, 779, 743, 697, 615, 554 cm–1.
MS (CI, CH4): m/z (%) = 289 (100) [M + H]+. HRMS (ESI): calcd.
for [M + H]+ 289.1705; found 289.1698.
C), 136.7, 140.5, 143.1, 148.7, 162.8 ppm. IR (film): ν = 3324, 3083,
˜
3063, 3027, 2832, 1670, 1583, 1568, 1496, 1475, 1450, 1434, 1117,
Preparation of Palladium Complexes: To a stirred solution of amine
1a–d (0.25 mmol) in freshly distilled MeOH (5 mL) was added
1025, 989, 743, 697, 615, 543 cm–1. MS (CI, NH3): m/z (%) = 275
(100) [M + H]+. HRMS (ESI):calcd. for [M + H]+ 275.1548; found Na2PdCl4 (74 mg, 0.25 mmol). The mixture was stirred at room
275.1551.
temperature for 16 h, and the solvent was removed by evaporation
under vacuum. The residue was then filtered through a silica gel
pad [firstly eluting with cyclohexane/EtOAc (7:3) to remove traces
of free amine, then eluting with EtOAc] to give the corresponding
palladium complexes.
N-Benzyl-N-[phenyl(pyrimidin-2-yl)methyl]amine (1b): Yield 436 mg
(79%); brown solid; Rf = 0.30 (50% EtOAc in cyclohexane); m.p.
1
73 °C. H NMR (300 MHz, CDCl3): δ = 2.48 (s, 1 H, NH), 3.64
(d, J = 13.1 Hz, 1 H), 3.73 (d, J = 13.1 Hz, 1 H), 5.03 (s, 1 H),
7.06 (t, J = 5.0 Hz, 1 H), 7.15–7.30 (m, 8 H), 7.38–7.41 (m, 2 H),
8.62 (d, J = 5.0 Hz, 2 H) ppm. H NMR (300 MHz, [D6]dmso): δ
Complex 2a: Yield 103 mg (92%); yellow powder; Rf = 0.60
(EtOAc). 1H NMR (300 MHz, [D6]dmso): δ = 3.95 (dd, J = 2.5
and 13.1 Hz, 1 H), 4.30 (dd, J = 4.2 and 13.1 Hz, 1 H), 5.46 (s, 1
H), 6.99 (s, 1 H, NH), 7.23–7.32 (m, 3 H), 7.34–7.39 (m, 2 H),
1
= 3.36 (s, 1 H, NH), 3.64 (s, 2 H), 4.94 (s, 1 H), 7.21–7.24 (m, 2
H), 7.27–7.32 (m, 6 H), 7.36 (t, J = 4.9 Hz, 1 H), 7.40–7.43 (m, 2
H), 8.77 (d, J = 4.9 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ 7.46–7.58 (m, 3 H), 7.88 (td, J = 1.4 and 7.7 Hz, 1 H), 7.95 (d, J
= 51.3, 67.5, 119.2, 127.0, 127.5, 127.8 (2 C), 128.4 (2 C), 128.5 (2
C), 128.6 (2 C), 139.9, 141.3, 157.2 (2 C), 170.9 ppm. IR (in KBr):
= 7.1 Hz, 4 H), 8.57 (d, J = 5.4 Hz, 1 H) ppm. 13C NMR (75 MHz,
[D6]dmso): δ = 57.8, 73.0, 123.4, 124.2, 128.6 (2 C), 128.8 (3 C),
129.5 (2 C), 129.6, 131.7 (2 C), 134.7, 137.9, 140.5, 148.9, 166.2
ν = 3304, 3083, 3053, 3017, 2940, 2843, 1783, 1562, 1491, 1460,
˜
1419, 1117, 1020, 820, 748, 697, 595, 549 cm–1. MS (CI, CH4): m/z
(%) = 276 (100) [M + H]+. HRMS (ESI): calcd. for [M + H]+
276.1501; found 276.1519.
ppm. IR (in KBr): ν = 3452, 3109, 3058, 3032, 2930, 2858, 1609,
˜
1496, 1475, 1455, 1440, 1424, 1163, 1143, 912, 764, 692, 554 cm–1.
MS [ESI, MeCN/MeOH (4:1)]: m/z (%) = 462–453 (100) [M – Cl
+ MeCN]+, 426–417 (50) [M – Cl – HCl + MeCN]+, 416–407 (10),
386–377 (15) [M – Cl – HCl]+. HRMS (ESI): calcd. for ([M – Cl –
HCl]+, 104Pd) 377.0432; found 377.0444. C19H18Cl2N2Pd (451.69):
calcd. C 50.52, H 4.02, N 6.20; found C 50.59, H 4.10, N 6.28.
N-Benzyl-N-[phenyl(pyrazin-2-yl)methyl]amine (1c): Yield 414 mg
(75%); yellow solid; Rf = 0.30 (30% EtOAc in cyclohexane); m.p.
1
79 °C. H NMR (300 MHz, CDCl3): δ = 2.59 (s, 1 H, NH), 3.62
(d, J = 13.2 Hz, 1 H), 3.69 (d, J = 13.2 Hz, 1 H), 4.90 (s, 1 H),
7.13–7.18 (m, 2 H), 7.20–7.26 (m, 6 H), 7.32–7.36 (m, 2 H), 8.28
(d, J = 2.7 Hz, 1 H), 8.37 (dd, J = 1.5 and 2.5 Hz, 1 H), 8.52 (d, J
Complex 2b: Yield 107 mg (95%); yellow powder; Rf = 0.65
(EtOAc). 1H NMR (300 MHz, [D6]dmso): δ = 3.97 (d, J = 12.7 Hz,
1 H), 4.31 (dd, J = 3.7 and 12.7 Hz, 1 H), 5.51 (s, 1 H), 7.08 (s, 1
1
= 1.50 Hz, 1 H) ppm. H NMR (300 MHz, [D6]dmso): δ = 3.41 (s,
1 H, NH), 3.62 (d, J = 13.7 Hz, 1 H), 3.68 (d, J = 13.7 Hz, 1 H), H, NH), 7.20–7.28 (m, 3 H), 7.39 (t, J = 5.3 Hz, 1 H), 7.45–7.54
4.95 (s, 1 H), 7.20–7.26 (m, 2 H), 7.30–7.35 (m, 6 H), 7.43–7.46 (m,
2 H), 8.49 (d, J = 2.5 Hz, 1 H), 8.54 (dd, J = 1.5 and 2.5 Hz, 1 H),
(m, 3 H), 7.93 (d, J = 6.8 Hz, 2 H), 7.99 (d, J = 6.5 Hz, 2 H), 8.64
(dd, J = 2.1 and 6.0 Hz, 1 H), 8.75 (dd, J = 2.1 and 4.9 Hz, 1 H)
8.83 (d, J = 1.50 Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = ppm. 13C NMR (75 MHz, [D6]dmso): δ = 57.5, 72.4, 120.5, 128.2
51.4, 65.3, 127.0, 127.6 (2 C), 127.7, 128.1 (2 C), 128.3 (2 C), 128.7
(2 C), 128.4 (2 C), 128.5, 129.0 (2 C), 129.3, 131.5 (2 C), 134.2,
(2 C), 139.6, 141.2, 142.9, 143.7, 144.0, 157.8 ppm. IR (in KBr): ν
136.2, 155.7, 159.7, 173.9 ppm. IR (in KBr): ν = 3447, 3150, 3073,
˜
˜
= 3298, 3048, 3022, 2919, 2832, 1470, 1450, 1404, 1112, 1061, 1015,
3027, 2925, 2848, 1778, 1588, 1552, 1501, 1450, 1419, 1363, 1255,
835, 753, 697, 620, 589, 538 cm–1. MS (CI, CH4): m/z (%) = 276
1096, 1035, 820, 769, 748, 707, 697, 661, 554 cm–1. MS [ESI,
(100) [M + H]+. HRMS (ESI): calcd. for [M + H]+ 276.1501; found MeCN/MeOH (4:1)]: m/z (%) = 463–454 (100) [M – Cl +MeCN]+,
276.1502.
425–414 (60), 413–406 (65), 387–378 (15) [M
–
Cl
–
Eur. J. Inorg. Chem. 2008, 2739–2745
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
2743